Cyrus Harmon Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

Cyrus Harmon is of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 761,283 shares of OLMA, which is worth approximately $8.39 Million. The most recent transaction as insider was on Jun 28, 2024, when has been sold 20,000 shares (Common Stock) at a price of $10.77 per share, resulting in proceeds of $215,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 761K

7.87% 3M change

26.71% 12M change

Total Value Held $8.39 Million

Cyrus Harmon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 28 2024	SELL Open market or private sale	$215,400 $10.77 p/Share	20,000 Reduced 2.56%	761,283 Common Stock
Jun 04 2024	SELL Open market or private sale	$61,650 $12.33 p/Share	5,000 Reduced 0.64%	781,283 Common Stock
Jun 03 2024	SELL Open market or private sale	$54,650 $10.93 p/Share	5,000 Reduced 0.63%	786,283 Common Stock
May 31 2024	SELL Open market or private sale	$141,150 $9.41 p/Share	15,000 Reduced 1.86%	791,283 Common Stock
May 06 2024	SELL Open market or private sale	$54,600 $10.92 p/Share	5,000 Reduced 0.62%	806,283 Common Stock
Apr 30 2024	SELL Open market or private sale	$142,650 $9.51 p/Share	15,000 Reduced 1.82%	811,283 Common Stock
Mar 28 2024	SELL Open market or private sale	$219,400 $10.97 p/Share	20,000 Reduced 2.36%	826,283 Common Stock

Feb 29 2024	SELL Open market or private sale	$317,750 $12.71 p/Share	25,000 Reduced 2.87%	846,283 Common Stock
Feb 01 2024	SELL Open market or private sale	$77,800 $15.56 p/Share	5,000 Reduced 0.57%	871,283 Common Stock
Jan 31 2024	SELL Open market or private sale	$305,750 $12.23 p/Share	25,000 Reduced 2.77%	876,283 Common Stock
Dec 29 2023	SELL Open market or private sale	$342,500 $13.7 p/Share	25,000 Reduced 2.7%	901,283 Common Stock
Nov 30 2023	SELL Open market or private sale	$314,250 $12.57 p/Share	25,000 Reduced 2.63%	926,283 Common Stock
Nov 22 2023	SELL Open market or private sale	$55,447 $13.9 p/Share	3,989 Reduced 0.42%	951,283 Common Stock
Nov 21 2023	SELL Open market or private sale	$62,293 $14.86 p/Share	4,192 Reduced 0.44%	955,272 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	15,750 Added 1.62%	959,464 Common Stock
Nov 02 2023	SELL Open market or private sale	$78,200 $15.64 p/Share	5,000 Reduced 0.53%	943,714 Common Stock
Oct 31 2023	SELL Open market or private sale	$301,250 $12.05 p/Share	25,000 Reduced 2.57%	948,714 Common Stock
Sep 29 2023	SELL Open market or private sale	$310,250 $12.41 p/Share	25,000 Reduced 2.5%	973,714 Common Stock
Sep 05 2023	SELL Open market or private sale	$116,199 $11.62 p/Share	10,000 Reduced 0.99%	998,714 Common Stock
Aug 31 2023	SELL Open market or private sale	$140,400 $9.36 p/Share	15,000 Reduced 1.47%	1,008,714 Common Stock
Aug 16 2023	SELL Open market or private sale	$152,100 $10.14 p/Share	15,000 Reduced 1.44%	1,023,714 Common Stock
Jun 08 2023	SELL Open market or private sale	$63,000 $6.3 p/Share	10,000 Reduced 0.95%	1,038,714 Common Stock
Jun 06 2023	SELL Open market or private sale	$31,450 $6.29 p/Share	5,000 Reduced 0.47%	1,048,714 Common Stock
Jun 05 2023	SELL Open market or private sale	$30,200 $6.04 p/Share	5,000 Reduced 0.47%	1,053,714 Common Stock
Nov 29 2021	SELL Open market or private sale	$9,904 $24.76 p/Share	400 Reduced 0.04%	1,051,146 Common Stock

Cyrus Harmon

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Value

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA

Account